Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
weightloss
![Should weight-loss drugs be given to children? Should weight-loss drugs be given to children?](https://i2.wp.com/res.cloudinary.com/glide/image/fetch/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fd1e00ek4ebabms.cloudfront.net%252Fproduction%252F7ad9f51b-5ab7-4283-b4ab-390e42823855.jpg%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?w=400&resize=400,400&ssl=1)
Should weight-loss drugs be given to children?
- By nasdaqpicks.com
- . 11 February 2025
Last spring, Chloe, a 15-year-old who lives in the US state of Georgia, was stuck. She had tried dieting with a nutritionist and exercising with
![Weight-Loss Drug Wegovy Cuts Heart Risk in New Study](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/08/Weight-Loss-Drug-Wegovy-Cuts-Heart-Risk-in-New-Study-400x400.jpeg)
Weight-Loss Drug Wegovy Cuts Heart Risk in New Study
- By nasdaqpicks.com
- . 8 August 2023
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
![Employers Cut Off Access to Weight-Loss Drugs for Workers](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/08/Employers-Cut-Off-Access-to-Weight-Loss-Drugs-for-Workers-400x400.jpeg)
Employers Cut Off Access to Weight-Loss Drugs for Workers
- By nasdaqpicks.com
- . 2 August 2023
Costs are mounting for popular drugs such as Wegovy, a cousin of Ozempic, and healthcare plans are restricting coverage to save money. Source link
![U.K. Reviews Safety of Ozempic, Other Weight-Loss Drugs](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/07/UK-Reviews-Safety-of-Ozempic-Other-Weight-Loss-Drugs-400x400.jpeg)
U.K. Reviews Safety of Ozempic, Other Weight-Loss Drugs
- By nasdaqpicks.com
- . 26 July 2023
Drug regulators said they have received several reports of suspected suicidal and self-injurious behavior in patients taking the drugs. Source link
![U.S. Supreme Court turns away challenge to Trump's tariffs on steel imports By Reuters](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/03/US-Supreme-Court-turns-away-challenge-to-Trumps-tariffs-on-400x400.jpg)
Strong U.S. demand eases pressure on Novo to show weight-loss drug’s health benefits By Reuters
- By nasdaqpicks.com
- . 14 July 2023
© Reuters. FILE PHOTO: A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S.,
![Biotech firms target weight-loss drugs without Wegovy's side-effects By Reuters](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/07/Biotech-firms-target-weight-loss-drugs-without-Wegovys-side-effects-By-Reuters-400x400.jpg)
Biotech firms target weight-loss drugs without Wegovy’s side-effects By Reuters
- By nasdaqpicks.com
- . 7 July 2023
© Reuters. FILE PHOTO: A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S.,
![Ozempic, Wegovy and Mounjaro Spark a Weight-Loss and Diet Industry Identity Crisis](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/04/Ozempic-Wegovy-and-Mounjaro-Spark-a-Weight-Loss-and-Diet-Industry-400x400.jpeg)
Ozempic, Wegovy and Mounjaro Spark a Weight-Loss and Diet Industry Identity Crisis
- By nasdaqpicks.com
- . 10 April 2023
Weight-loss businesses, which long pushed calorie-counting and willpower, are grappling with the surging popularity of new drugs. Source link
![Hype Around Weight-Loss Drugs Shows No Signs of Abating. Neither Do the Ads.](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/04/Hype-Around-Weight-Loss-Drugs-Shows-No-Signs-of-Abating-Neither-400x400.jpeg)
Hype Around Weight-Loss Drugs Shows No Signs of Abating. Neither Do the Ads.
- By nasdaqpicks.com
- . 4 April 2023
Ads for the likes of Ozempic and Wegovy are spreading through social media feeds, subway stations and TV. Source link
![The 'King Kong' of Weight-Loss Drugs Is Coming](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/04/The-039King-Kong039-of-Weight-Loss-Drugs-Is-Coming-400x400.jpeg)
The 'King Kong' of Weight-Loss Drugs Is Coming
- By nasdaqpicks.com
- . 3 April 2023
Eli Lilly’s Mounjaro could outpace Ozempic as the most powerful treatment on the market. To develop it, the drug company needed to overhaul long-held but
![US doctor groups debate best use of new weight-loss drugs By Reuters](https://i0.wp.com/www.nasdaqpicks.com/wp-content/uploads/2023/03/US-doctor-groups-debate-best-use-of-new-weight-loss-drugs-400x400.jpg)
US doctor groups debate best use of new weight-loss drugs By Reuters
- By nasdaqpicks.com
- . 30 March 2023
2/2 © Reuters. FILE PHOTO: The American Medical Association logo is seen at their office in Washington, D.C., U.S., August 30, 2020. REUTERS/Andrew Kelly/ 2/2